Jason King

Jason King is an accomplished professional with extensive experience in business development and gene therapy. Currently serving as the Director of Business Development at Ascend Advanced Therapies, Jason has previously held similar roles at OXGENE, where Jason introduced clients to scalable platforms for cell and gene therapy manufacturing. A co-founder of Strathroslin, Jason has expertise in 3D tissue engineering for pre-clinical applications. Jason's R&D background includes significant contributions at Roslin Cell Sciences and Censo Biotechnologies, along with a notable publication history. With a solid educational foundation that includes an MBA from The University of Edinburgh and a PhD in Virology, Jason's career spans numerous prestigious institutions, highlighting a strong commitment to advancing gene therapy technologies.